Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of age and insulin resistance with sex hormone-binding globulin levels in healthy men.

Archives of endocrinology and metabolism·2025
Same author

Impact of the COVID-19 pandemic on the incidence of central precocious puberty: A PRISMA-ScR-COMPLIANT scoping review.

Archives of endocrinology and metabolism·2025
Same author

Doppler Assessment of the Uterine Arteries Is a Valuable Adjunct Tool for the Evaluation of Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls with Central Precocious Puberty.

Neuroendocrinology·2025
Same author

Effects of nurse tele support via telephone calls on transition between specialized and primary care in type 2 diabetes mellitus patients: a CONSORT-compliant randomized clinical trial.

Endocrine·2024
Same author

Is race adjustment necessary to estimate glomerular filtration rate in South Brazilians?

Journal of nephrology·2024
Same author

2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis.

Clinical kidney journal·2023

Related Experiment Video

Updated: Jun 8, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Diabetes mellitus classification.

Jorge de Faria Maraschin1, Nádia Murussi, Vanessa Witter

  • 1Universidade Federal do Rio Grande do Sul, Porto Alegre, RS. jorge.voy@terra.com.br

Arquivos Brasileiros De Cardiologia
|September 22, 2010
PubMed
Summary

Accurate diabetes mellitus (DM) classification is crucial for effective treatment. This review analyzes antibodies and C-peptide tests to refine DM subtypes, improving diagnosis and understanding of pathogenesis.

More Related Videos

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

Related Experiment Videos

Last Updated: Jun 8, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

Area of Science:

  • Endocrinology and Metabolism
  • Immunology
  • Clinical Diagnostics

Background:

  • Current diabetes mellitus (DM) classification includes four main types, but overlaps exist, especially in young adults or those presenting with diabetic ketoacidosis.
  • Subtypes of DM often require more precise classification beyond traditional categories to guide appropriate treatment strategies.
  • Assessing autoimmunity via antibodies and beta-cell function through C-peptide levels are proposed additions to enhance DM classification.

Purpose of the Study:

  • To review and analyze the performance of diagnostic indexes, specifically antibodies and C-peptide measurements, in classifying diabetes mellitus.
  • To detail the characteristics of DM subtypes based on autoimmunity and beta-cell function.
  • To explore how these markers can refine DM classification for improved patient management and etiological understanding.

Main Methods:

  • Literature review focusing on studies evaluating antibody presence (e.g., anti-insulin, anti-glutamic acid decarboxylase) and C-peptide levels in DM patients.
  • Analysis of C-peptide stimulation tests (post-meal or intravenous glucagon) to assess pancreatic insulin reserve.
  • Categorization of DM subtypes based on the combination of antibody status (A+) and C-peptide levels (β+).

Main Results:

  • Antibodies confirm autoimmune activity; anti-insulin antibodies are more accurate in younger children, while anti-glutamic acid decarboxylase antibodies are more reliable in adults and persist longer.
  • C-peptide levels below 1.5 ng/ml indicate absent pancreatic function, while higher levels suggest preserved function.
  • A combined approach using antibodies (A+) and C-peptide (β+) allows for subdivision into Type 1A (A+β-), 1B (A+β-), 2A (A+β+), and 2B (A-β+), offering more precise classification.

Conclusions:

  • Integrating antibody and C-peptide assessments provides a more precise classification of diabetes mellitus subtypes.
  • This refined classification aids in tailoring treatment strategies and deepens the understanding of DM pathogenesis.
  • The proposed classification system (e.g., Type 1A, 1B, 2A, 2B) enhances diagnostic accuracy and clinical decision-making for diabetes management.